Enable Injections Announces $30 Million Investment from Sanofi to Accelerate Manufacturing Capabilities
CINCINNATI, Jan. 06, 2026 (GLOBE NEWSWIRE) — Enable Injections, Inc. (“Enable”) a healthcare innovation company developing and manufacturing the enFuse(R) On-Body Delivery System (OBDS), announced today that Sanofi is making a $30 million investment to accelerate Enable's manufacturing build-out, strengthen its supply chain capabilities, and drive commercial growth. “This investment from one of our key […]